Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.

NanoVibronix Inc

NAOV
0,52
0,1365 (35,59%)
31 Gen 2025 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
27/1/202514:04EDGAR2Form DEF 14A - Other definitive proxy statements
16/1/202512:15EDGAR2Form PRE 14A - Other preliminary proxy statements
07/1/202514:00EDGAR2Form 8-K - Current report
07/1/202514:00BWNanoVibronix Advances Development of PainShield and..
06/1/202514:15EDGAR2Form 8-K - Current report
06/1/202514:00BWNanoVibronix Announces Completion of Pilot Phase of Clinical..
03/1/202503:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202503:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202503:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202503:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/12/202422:05EDGAR2Form 8-K - Current report
19/12/202416:13EDGAR2Form 8-K - Current report
11/12/202422:25EDGAR2Form 8-K - Current report
11/12/202414:00BWNanoVibronix Secures $12 Million Minimum Purchase Commitment..
22/11/202422:18EDGAR2Form 8-K - Current report
14/11/202423:17EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
14/11/202421:12EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/11/202414:00BWNanoVibronix Provides Business Update
29/10/202421:29EDGAR2Form ARS - Annual Report to Security Holders
29/10/202421:26EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
29/10/202421:18EDGAR2Form DEF 14A - Other definitive proxy statements
11/10/202422:51EDGAR2Form 8-K - Current report
09/10/202414:30BWNanoVibronix Takes Next Step to Partner with Specialist..
25/9/202423:00EDGAR2Form 8-K - Current report
23/9/202414:30BWNanoVibronix Signs Letter of Intent with Potential New..
21/8/202414:30BWNanoVibronix Highlights Second Quarter Revenue Growth and..
14/8/202422:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
22/5/202414:30BWNanoVibronix Announces Commencement of UroShield Clinical..
16/5/202422:05EDGAR2Form 8-K - Current report
16/5/202414:30BWNanoVibronix Issues Letter to Stockholders
15/5/202419:25EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/5/202414:30BWNanoVibronix Announces Distribution Agreement with VA..
01/5/202414:00BWNanoVibronix Announces PainShield Will Be Included in..
09/4/202414:30BWNanoVibronix Issues Letter to Stockholders
28/3/202413:30BWNanoVibronix Signs Agreement for Research and Development of..
26/2/202423:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/2/202401:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/2/202401:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/2/202401:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/2/202401:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 0,5484 Min: 0,48141 Max: 0,67
Chiusura: 0,3835

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network